2-{2-[5-(4-chlorophenyl)-3-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[5-(4-chlorophenyl)-3-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[5-(4-chlorophenyl)-3-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
Compound ID: | E239-0196 |
Compound Name: | 2-{2-[5-(4-chlorophenyl)-3-(2,5-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
Molecular Weight: | 549.05 |
Molecular Formula: | C28 H25 Cl N4 O4 S |
Smiles: | COc1ccc(c(c1)C1CC(c2ccc(cc2)[Cl])N(C2=NC(C(CC(Nc3ccccc3)=O)S2)=O)N=1)OC |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 5.2901 |
logD: | 5.29 |
logSw: | -6.0016 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 74.146 |
InChI Key: | RYSGOGRPSHTAMJ-UHFFFAOYSA-N |